On Monday, President Yoon Suk Yeol came forward to explain his plan to increase the medical school enrollment quota by 2,000 and persuade resigned trainee doctors to return to teaching hospitals.In conclusion, however, medical sources said Yoon’s 50-minute speech hardened the junior doctors’ determi
Hanmi Pharm, a Korean pharmaceutical giant, said on Tuesday that it submitted an investigational new drug (IND) application to the U.S. FDA on March 29 for its next-generation GLP-1/GIP/GCG triple-agonist, named HM15275, to initiate a phase 1 clinical trial targeting obesity.The trial will assess th
Daewoong Pharmaceutical said it signed a strategic partnership with Chong Kun Dang Pharm. to co-market Fexuclue (ingredient: Fexuprazan), the 34th domestically developed new drug in Korea and a treatment for gastroesophageal reflux disease (GERD).With the signing of the cooperation agreement, the tw
Ybrain, a local mental health therapeutics company, entered into a strategic partnership with Friend & Companion, a specialized MSO (Management Service Organization) and CRO (Clinical Research Organization) company, to co-market its proprietary electroencephalogram diagnostic device, MINDD SCAN.MIND
Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate-to-severe plaque psoriasis in adults, receives health insurance benefits in Korea for treating adult patients with chronic severe plaque psoriasis.The first TYK2 inhibitor and once-daily oral treatment approved for modera
oncoMASTER, a Korean cancer precision medicine company, said it has been designated as a member of Nvidia's startup incubation program Inception.oncoMASTER is a subsidiary of Korea University Medical Technology Holdings and was established based on the achievements of the K-Master Project Corps, whi
Orion, a Korean confectionary company, has become the largest shareholder of antibody-drug conjugate (ADC) drug developer LigaChem Biosciences (formerly LegoChem Biosciences) by paying all of its stock purchase prices.On March 29, Orion announced that it has completed the payment of 548.5 billion wo
President Yoon Suk Yeol has strongly reaffirmed the government's commitment to increase the medical school admission quota, aiming to tackle a persistent issue that has faced numerous setbacks in past administrations.In a statement from the Presidential Office in Yongsan on Monday, President Yoon ca
Merck Biopharma Korea's superovulation induction injection Pergoveris (follitropin alpha) will receive expanded reimbursement to treat patients with severe luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiencies from Monday.Pergoveris is a superovulation induction injection cont
Leqvio (inclisiran), a cholesterol management drug that requires only two subcutaneous injections per year, is preparing to land in Korea.The Ministry of Food and Drug Safety (MFDS) is reportedly reviewing Novartis Korea's application to license Leqvio. Approval is expected as early as the first hal
JW Pharmaceutical said Monday that interim results from a long-term study of Hemlibra (emicizumab) in children with severe non-antibody hemophilia A confirmed that the drug improved joint health in patients.Hemlibra is a breakthrough medicine that mimics factor 8, a blood clotting factor deficient i
Lunit, a medical artificial intelligence (AI) company, said Monday it would present seven research findings using its AI biomarker platform, Lunit Scope, at the American Association for Cancer Research (AACR) 2024 in San Diego, Calif., from April 5-10.In a poster presentation, Lunit will demonstrate
MSD Korea said its new 15-valent pneumococcal protein conjugate vaccine, Vaxneuvance, will be available for free at hospitals and clinics nationwide starting Monday as part of the National Immunization Program (NIP) for children.Vaxneuvance is indicated for preventing invasive disease and pneumonia
A 33-month-old girl, rescued from an irrigation ditch while her parents were working on a farm in Boeun, North Chungcheong Province, died after a tertiary hospital refused to receive her, local media reports said. Nonetheless, an emergency medicine specialist noted that a tertiary hospital transfer
Daewoong Pharmaceutical's new Co-CEO Park Seong-soo, promoted from vice president, vowed to achieve 1 trillion won ($741.8 million) in operating profit under his leadership.Park was appointed as the company's new co-CEO following a board meeting held on Thursday.This strategic move transitions the c
Quratis, a Kosdaq-listed biotech company, said Friday that it has decided to establish a local corporation in the Philippines to tap into the country's tuberculosis vaccine market.Quratis has submitted an investigative new drug (IND) application for a phase 2b/3 clinical trial of “QTP101,” a TB vacc
The Korean government said its funding to hospitals for surgeries on severely ill children will drastically increase.The Ministry of Health and Welfare announced the "Pediatric Essential Medical Care Fee Plan" on Friday at a regular briefing of the Central Disaster and Safety Headquarters.Since last
Students from 40 medical schools nationwide have set about to file a class action lawsuit against the government to prevent the government from increasing the medical school enrollment quota.The Korean Association of Medical Colleges and Medical Graduate Schools (KAMC) has begun recruiting participa
After the plans to integrate Hanmi Group with OCI Holdings fell through, Hanmi officials withdrew from their nominations as internal directors at OCI Holdings.This development came ahead of OCI Holdings’ annual shareholders' general meeting on Friday, signaling a significant shift in the relationshi
On a bustling afternoon on Thursday, just minutes past 3:00 p.m., an outpour of cheers erupted from the crowd-packed SINTEX Hall in Suwon Science College in Suwon, Gyeonggi Province.The applause and shouts nearly blew the speakers in the press room as the two-month-long managerial dispute within the